[천지일보=홍보영 기자] Dong-A ST announced that it held the 8th regular shareholders’ meeting at 9 am on the 24th in the auditorium on the 7th floor of its headquarters in Yongdu-dong, Dongdaemun-gu, with shareholders and company management attending.
At the board of directors held after the general shareholders’ meeting, Chairman Um Dae-sik and President Han Jong-Hyun were each appointed as CEOs.
At the regular general meeting of shareholders on this day, approval of the 8th financial statements (including the statement of appropriation of retained earnings (draft)) and consolidated financial statements, partial amendments to the articles of incorporation, appointment of directors, appointment of outside directors to become members of the audit committee, appointment of members of the audit committee, and remuneration limits for directors. A total of six approved agenda items were proposed and all passed according to the original plan.
In the 8th fiscal report, Dong-A ST reported that sales and operating profit were KRW 586 billion and KRW 34.1 billion, respectively, falling 4.2% and 40.2% compared to the previous year, based on separate financial statements in 2020. After that, the approval of the financial statements and consolidated financial statements and the implementation of cash dividends of 1,000 won per common share were decided and decided.
In accordance with the amendment of the Commercial Act and the enforcement of the Act on Electronic Registration of Stocks and Bonds (Electronic Securities Act), some changes in the articles of incorporation were also approved.
Dong-A ST Chairman Uhm Dae-sik was reappointed as the inside director, and Han Jong-Hyun was newly appointed.
As outside directors and audit committee members, Hee-ju Choi, adviser of Yulchon law firm, and Professor Jae-sang Ryu of Ewha Womans University, have been re-elected. In particular, outside director Jae-sang Ryu was elected separately in accordance with the amendment of the Commercial Act that one of the members of the audit committee must be separately elected.
Dong-A ST consists of a majority of the outside directors, and the CEO and the chairman of the board of directors are separated, and the outside director serves as the chairman of the board of directors, which is the subject of internal decision making in order to enhance transparency of governance structure and shareholder value. The Evaluation and Compensation Committee and the Audit Committee, which are internal committees of the BOD, are all composed of outside directors, and the Outside Director Candidate Recommendation Committee consists of more than two-thirds of outside directors.
Dong-A ST Chairman Uhm Dae-sik, Chairman of the General Shareholders’ Meeting, said in a greeting, “Dong-A ST’s overall sales declined due to the Corona 19 pandemic last year, but in the specialty drug sector, sales exceeded the market growth rate. “In the R&D field, this year, we will focus on global development of the biosimilar DMB-3115 of Stellara, a psoriasis treatment, and we plan to develop new drugs and conduct preclinical trials of new pipelines.”
‘;
Copyright © Cheonji Ilbo-Unauthorized reproduction and redistribution of the press release of hope for a new era is prohibited.